Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

University Hospital, Rouen4 enrolled

Overview

In case of lack of compliance in HIV1 patients, the investigators hope to prove that enfuvirtide injection during almost 3 months, with nurse help at home and therapeutic education may contribute to obtain a good compliance more than 95% in these patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV1 Infection HIV Infections

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * virological failure, more than 18 years, prouved lack of compliance, with no sub-optimal treatment, in ambulatory status. Exclusion Criteria: * hospitalization,HIV2 infection,pregnancy,preliminary treatment with enfuvirtide,chimiotherapy , opportunistic infection in progress

Locations (1)

Borsa-Lebas

Rouen, France

Outcomes

Primary Outcomes

viral load compliance

Time frame: one year

Secondary Outcomes

statistical analysis of MOS HIV

Time frame: one year